Literature DB >> 10332071

Effect of chitosan on epithelial permeability and structure.

V Dodane1, M Amin Khan, J R Merwin.   

Abstract

Numerous studies have shown that chitosan, a mucoadhesive polymer, is a potential enhancer for transmucosal drug delivery. To further understand the mechanisms involved in chitosan action on the mucosal barrier, the activity of chitosan on the function and structure of monolayers of intestinal epithelial cells was investigated. In Caco-2 cells, chitosan caused a reversible, time and dose-dependent decrease in transepithelial electrical resistance. The effect of chitosan on tight junctions was confirmed by an increased permeability coefficient for mannitol transport when cells were treated with 0.1-0.5% w/v chitosan solution for 60 min compared to control cells. Involvement of tight junctions was visualized by confocal scanning microscopy using occludin and ZO-1, tight junctional proteins. Following an incubation with 0.01 or 0.1% w/v chitosan, labeling of both proteins varied in localization and decreased in fluorescent intensity at the cell periphery. In addition, a focal condensation of actin was observed preferentially at areas of cell-to-cell contacts. However, after 24-h recovery, the cell structure resembled untreated control cells. Simultaneous addition of cycloheximide, a protein synthesis inhibitor, prevented full recovery. This implied that protein synthesis was required for the cells to return to baseline levels. Chitosan treatment appeared to slightly perturb the plasma membrane as assessed by an increased release of lactate dehydrogenase. However, addition of 0.5% chitosan for 60 min did not affect cell viability as shown by Trypan blue dye exclusion. These data suggest that chitosan increases cell permeability by affecting paracellular and intracellular pathways of epithelial cells, in a reversible manner. Copyright.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10332071     DOI: 10.1016/s0378-5173(99)00030-7

Source DB:  PubMed          Journal:  Int J Pharm        ISSN: 0378-5173            Impact factor:   5.875


  62 in total

1.  Transfection of mEpo gene to intestinal epithelium in vivo mediated by oral delivery of chitosan-DNA nanoparticles.

Authors:  Jing Chen; Wu-Li Yang; Ge Li; Ji Qian; Jing-Lun Xue; Shou-Kuan Fu; Da-Ru Lu
Journal:  World J Gastroenterol       Date:  2004-01       Impact factor: 5.742

Review 2.  Absorption enhancers for nasal drug delivery.

Authors:  Stanley S Davis; Lisbeth Illum
Journal:  Clin Pharmacokinet       Date:  2003       Impact factor: 6.447

3.  Effect of chitosan on epithelial cell tight junctions.

Authors:  Jennifer Smith; Edward Wood; Michael Dornish
Journal:  Pharm Res       Date:  2004-01       Impact factor: 4.200

4.  Insulin-loaded nanoparticles based on N-trimethyl chitosan: in vitro (Caco-2 model) and ex vivo (excised rat jejunum, duodenum, and ileum) evaluation of penetration enhancement properties.

Authors:  Giuseppina Sandri; Maria Cristina Bonferoni; Silvia Rossi; Franca Ferrari; Cinzia Boselli; Carla Caramella
Journal:  AAPS PharmSciTech       Date:  2010-03-16       Impact factor: 3.246

5.  Pharmacokinetics and pharmacodynamics of nasally delivered midazolam.

Authors:  Manuel Haschke; Katja Suter; Sarah Hofmann; Robert Witschi; Johannes Fröhlich; Georgios Imanidis; Jürgen Drewe; Thomas A Briellmann; Franz E Dussy; Stephan Krähenbühl; Christian Surber
Journal:  Br J Clin Pharmacol       Date:  2010-06       Impact factor: 4.335

6.  Enhancement of nose-brain delivery of therapeutic agents for treating neurodegenerative diseases using peppermint oil.

Authors:  S R Kiran Vaka; S Narasimha Murthy
Journal:  Pharmazie       Date:  2010-09       Impact factor: 1.267

Review 7.  Critical role of tight junctions in drug delivery across epithelial and endothelial cell layers.

Authors:  L González-Mariscal; P Nava; S Hernández
Journal:  J Membr Biol       Date:  2005-09       Impact factor: 1.843

8.  Intravesical immunotherapy of superficial bladder cancer with chitosan/interleukin-12.

Authors:  David A Zaharoff; Benjamin S Hoffman; H Brooks Hooper; Compton J Benjamin; Kiranpreet K Khurana; Kenneth W Hance; Connie J Rogers; Peter A Pinto; Jeffrey Schlom; John W Greiner
Journal:  Cancer Res       Date:  2009-07-28       Impact factor: 12.701

9.  Carbohydrate biopolymers enhance antibody responses to mucosally delivered vaccine antigens.

Authors:  A Bacon; J Makin; P J Sizer; I Jabbal-Gill; M Hinchcliffe; L Illum; S Chatfield; M Roberts
Journal:  Infect Immun       Date:  2000-10       Impact factor: 3.441

10.  Spray-dried mucoadhesive microspheres: preparation and transport through nasal cell monolayer.

Authors:  Saraporn Harikarnpakdee; Vimolmas Lipipun; Narueporn Sutanthavibul; Garnpimol C Ritthidej
Journal:  AAPS PharmSciTech       Date:  2006-02-10       Impact factor: 3.246

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.